BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21539848)

  • 1. Carisbamate has powerful disease-modifying effects in the lithium-pilocarpine model of temporal lobe epilepsy.
    François J; Germe K; Ferrandon A; Koning E; Nehlig A
    Neuropharmacology; 2011; 61(1-2):313-28. PubMed ID: 21539848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive behavioral evaluation in the lithium-pilocarpine model in rats: effects of carisbamate administration during status epilepticus.
    Faure JB; Akimana G; Carneiro JE; Cosquer B; Ferrandon A; Geiger K; Koning E; Penazzi L; Cassel JC; Nehlig A
    Epilepsia; 2013 Jul; 54(7):1203-13. PubMed ID: 23663139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy.
    François J; Koning E; Ferrandon A; Nehlig A
    Epilepsy Res; 2006 Dec; 72(2-3):147-63. PubMed ID: 16945504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketogenic diet exhibits neuroprotective effects in hippocampus but fails to prevent epileptogenesis in the lithium-pilocarpine model of mesial temporal lobe epilepsy in adult rats.
    Linard B; Ferrandon A; Koning E; Nehlig A; Raffo E
    Epilepsia; 2010 Sep; 51(9):1829-36. PubMed ID: 20633040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between neuronal loss and interictal glucose metabolism during the chronic phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat.
    Dubé C; Boyet S; Marescaux C; Nehlig A
    Exp Neurol; 2001 Feb; 167(2):227-41. PubMed ID: 11161611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and histological assessment of the effect of intermittent feeding in the pilocarpine model of temporal lobe epilepsy.
    Parinejad N; Keshavarzi S; Movahedin M; Raza M
    Epilepsy Res; 2009 Sep; 86(1):54-65. PubMed ID: 19505798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model.
    André V; Dubé C; François J; Leroy C; Rigoulot MA; Roch C; Namer IJ; Nehlig A
    Epilepsia; 2007; 48 Suppl 5():41-7. PubMed ID: 17910580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizure susceptibility and the brain regional sensitivity to oxidative stress in male and female rats in the lithium-pilocarpine model of temporal lobe epilepsy.
    Peternel S; Pilipović K; Zupan G
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):456-62. PubMed ID: 19439251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy.
    Rigoulot MA; Koning E; Ferrandon A; Nehlig A
    J Pharmacol Exp Ther; 2004 Feb; 308(2):787-95. PubMed ID: 14593082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Temporal lobe epilepsy model induced by pilocarpine in rats].
    Li GL; Xiao B; Xie GJ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):29-32. PubMed ID: 12934390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the inherited genetic background on the consequences of lithium-pilocarpine status epilepticus: study in Genetic Absence Epilepsy Rats from Strasbourg and Wistar audiogenic rats.
    Hanaya R; Koning E; Ferrandon A; Nehlig A
    Neurobiol Dis; 2008 Sep; 31(3):451-8. PubMed ID: 18638555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy.
    Polascheck N; Bankstahl M; Löscher W
    Exp Neurol; 2010 Jul; 224(1):219-33. PubMed ID: 20353773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization.
    Mazzuferi M; Kumar G; Rospo C; Kaminski RM
    Exp Neurol; 2012 Dec; 238(2):156-67. PubMed ID: 22960187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy.
    Leroy C; Poisbeau P; Keller AF; Nehlig A
    J Physiol; 2004 Jun; 557(Pt 2):473-87. PubMed ID: 15034126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of hippocampal GAbaergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy.
    André V; Marescaux C; Nehlig A; Fritschy JM
    Hippocampus; 2001; 11(4):452-68. PubMed ID: 11530850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy.
    Pitkänen A; Nissinen J; Nairismägi J; Lukasiuk K; Gröhn OH; Miettinen R; Kauppinen R
    Prog Brain Res; 2002; 135():67-83. PubMed ID: 12143371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pinealectomy and the treatment with melatonin on the temporal lobe epilepsy in rats.
    de Lima E; Soares JM; del Carmen Sanabria Garrido Y; Gomes Valente S; Priel MR; Chada Baracat E; Abrão Cavalheiro E; da Graça Naffah-Mazzacoratti M; Amado D
    Brain Res; 2005 May; 1043(1-2):24-31. PubMed ID: 15862514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The delta opioid receptor agonist, SNC80, has complex, dose-dependent effects on pilocarpine-induced seizures in Sprague-Dawley rats.
    Bausch SB; Garland JP; Yamada J
    Brain Res; 2005 May; 1045(1-2):38-44. PubMed ID: 15910761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention and executive functions in a rat model of chronic epilepsy.
    Faure JB; Marques-Carneiro JE; Akimana G; Cosquer B; Ferrandon A; Herbeaux K; Koning E; Barbelivien A; Nehlig A; Cassel JC
    Epilepsia; 2014 May; 55(5):644-653. PubMed ID: 24621352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor map expansion in the pilocarpine model of temporal lobe epilepsy is dependent on seizure severity and rat strain.
    Young NA; Vuong J; Ozen LJ; Flynn C; Teskey GC
    Exp Neurol; 2009 Jun; 217(2):421-8. PubMed ID: 19361501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.